157 related articles for article (PubMed ID: 2430692)
1. Enhanced expression of the N-myc gene in Wilms' tumors.
Nisen PD; Zimmerman KA; Cotter SV; Gilbert F; Alt FW
Cancer Res; 1986 Dec; 46(12 Pt 1):6217-22. PubMed ID: 2430692
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
3. Expression of the N-myc oncogene in Wilms' tumour and related tissues.
Shaw AP; Poirier V; Tyler S; Mott M; Berry J; Maitland NJ
Oncogene; 1988 Aug; 3(2):143-9. PubMed ID: 2842712
[TBL] [Abstract][Full Text] [Related]
4. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
[TBL] [Abstract][Full Text] [Related]
5. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
Yao M; Shuin T; Misaki H; Kubota Y
Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
9. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid-induced growth suppression of blastemal Wilms' tumor.
Vincent TS; Re GG; Hazen-Martin DJ; Tarnowski BI; Willingham MC; Garvin AJ
Pediatr Pathol Lab Med; 1996; 16(5):777-89. PubMed ID: 9025876
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
Udtha M; Lee SJ; Alam R; Coombes K; Huff V
Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
[TBL] [Abstract][Full Text] [Related]
12. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
13. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
14. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
15. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.
Rouah E; Wilson DR; Armstrong DL; Darlington GJ
Cancer Res; 1989 Apr; 49(7):1797-801. PubMed ID: 2924321
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.
Martinerie C; Huff V; Joubert I; Badzioch M; Saunders G; Strong L; Perbal B
Oncogene; 1994 Sep; 9(9):2729-32. PubMed ID: 7520150
[TBL] [Abstract][Full Text] [Related]
18. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
Ibson JM; Rabbitts PH
Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
[TBL] [Abstract][Full Text] [Related]
19. Myc family of cellular oncogenes.
DePinho R; Mitsock L; Hatton K; Ferrier P; Zimmerman K; Legouy E; Tesfaye A; Collum R; Yancopoulos G; Nisen P
J Cell Biochem; 1987 Apr; 33(4):257-66. PubMed ID: 3034933
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
